| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
Immunosuppressive agentsReceptor (PPAR)Liver (Transplantation)MSHGhrelinImmune deviationEcstasyAdenosineRegulatory T cellCD39CD73NeutrophilsArginase| 1 | 1996 | Immunosuppression in organ transplantation. | 
| + | - | nl | Jpn J Pharmacol 71(2):89-100 (1996) |
| 2 | 1994 | Therapeutic advances in immunosuppression. | 
| + | - | nl | Clin Exp Immunol 98(3):351-7 (1994) |
| 3 | 1999 | Newer immunosuppressive drugs: a review. | 
| + | - | nl | J Am Soc Nephrol 10(6):1366-80 (1999) |
| 4 | 2008 | Pharmacokinetic principles of immunosuppressive drugs. | 
| + | - | nl | Ann Transplant 13(3):5-10 (2008) |
| 5 | 2008 | Therapeutic blockade of T-cell antigen receptor signal transduction and costimulation in autoimmune disease. | 
| + | - | nl | Adv Exp Med Biol 640(-):234-51 (2008) |
| 6 | 2009 | The pharmacology of immunosuppression. | 
| + | - | nl | Am J Pharm Educ 73(8):144 (2009) |
| 7 | 2007 | PPARs and molecular mechanisms of transrepression. | 
| + | - | nl | Biochim Biophys Acta 1771(8):926-35 (2007) |
| 8 | 2005 | Immunosuppression in liver transplantation: beyond calcineurin inhibitors. | 
| + | - | nl | Liver Transpl 11(3):267-80 (2005) |
| 9 | 2008 | Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. | 
| + | - | nl | Endocr Rev 29(5):581-602 (2008) |
| 10 | 2009 | Ghrelin: friend or foe for neuroinflammation. | 
| + | - | nl | Discov Med 8(41):64-7 (2009) |
| 11 | 2010 | Methylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern? | 
| + | - | nl | Br J Pharmacol 161(1):17-32 (2010) |
| 12 | 2008 | Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells. | 
| + | - | nl | Br J Pharmacol 153 Suppl 1(-):S457-64 (2008) |
| 13 | 2009 | Arginase: an emerging key player in the mammalian immune system. | 
| + | - | nl | Br J Pharmacol 158(3):638-51 (2009) Munder M |